DBV Technologies S.a. insider trading
Every open-market purchase and sale by DBV Technologies S.a.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $0 0 trades by 0 insiders Insider sales, 5 years $15.5M 6 trades by 2 insiders
3 months later: median −9.1% (−9.9% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following DBV Technologies S.a.’s insiders pay?
From August 3, 2023 to December 19, 2025, 5 insiders reported 3 open-market purchases and 2 sales not made under a pre-set plan in DBV Technologies S.a.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Epic Bpifrance | Other | 0 | — | — | 1 | — | December 19, 2025 |
| Mohideen Pharis | Chief Medical Officer | 0 | — | — | 1 | — | November 25, 2025 |
| Morris Timothy E | Director | 1 | — | — | 0 | — | August 28, 2023 |
| Soland Daniel B | Director | 1 | — | — | 0 | — | August 3, 2023 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER | 1 | — | — | 0 | — | March 11, 2024 |